foslevodopa/foscarbidopa improves nocturia symptoms in patients with parkinson’s disease
Published 11 months ago • 504 plays • Length 1:20Download video MP4
Download video MP3
Similar videos
-
3:02
subcutaneous 24-hour infusion of foslevodopa/foscarbidopa improves motor symptoms in pd patients
-
1:18
interim results of sc foslevodopa/foscarbidopa in parkinson’s disease
-
2:20
phase ii study of ne3107 in levodopa/carbidopa-treated patients with parkinson's disease
-
1:13
extending the efficacy of levodopa in patients with parkinson’s disease
-
0:50
subcutaneous levodopa/carbidopa infusion for parkinson's disease
-
1:29
benefits and challenges associated with subcutaneous infusions for parkinson’s disease
-
3:02
improvements to levodopa-based treatments for parkinson’s disease
-
2:37
long-term effectiveness of levodopa-carbidopa intestinal gel in parkinson's disease
-
2:35
levodopa dose adjustment versus adjunctive therapy in parkinson’s disease
-
18:15
long-acting, subcutaneous levodopa in parkinson's disease: is it safe?
-
0:51
how can continuous dopaminergic delivery improve outcomes in pd?
-
2:32
latest approaches to improve the delivery of levodopa
-
3:31
emerging subcutaneous infusions for pd: efficacy & infusion site reactions
-
4:39
levodopa and the pharmacological revolution in parkinson's disease
-
3:32
adequately treating parkinson disease with levodopa
-
3:31
nd0612 vs oral immediate-release levodopa/carbidopa in patients with pd and motor fluctuations
-
3:08
pdf's dr james beck discusses fda approval of nuplazid for symptoms of parkinson's psychosis
-
1:48
parkinetics: improved motion data collection of parkinson’s patients in everyday life
-
28:14
let's talk parkinson's - the connection between parkinson's disease, pelvic floor and incontinence